16.07.2021 17:45:00
|
Albany Molecular Research, Inc. -- Moody's downgrades Curia's (f/k/a AMRI) CFR to B3; affirms first lien ratings at B2; outlook stable
Rating Action: Moody's downgrades Curia's (f/k/a AMRI) CFR to B3; affirms first lien ratings at B2; outlook stableRead the full article at Moody's